Effect of anti-tuberculosis treatment on the systemic levels of tissue Inhibitors of metalloproteinases in tuberculosis – diabetes co-morbidity

MLA

Pavan Kumar, Nathella, et al. “Effect of Anti-Tuberculosis Treatment on the Systemic Levels of Tissue Inhibitors of Metalloproteinases in Tuberculosis – Diabetes Co-Morbidity.” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, no. Preprints, Jan. 2021. EBSCOhost, https://doi.org/10.1016/j.jctube.2021.100237.

APA

Pavan Kumar, N., Moideen, K., Viswanathan, V., Sivakumar, S., Hissar, S., Kornfeld, H., & Babu, S. (2021). Effect of anti-tuberculosis treatment on the systemic levels of tissue Inhibitors of metalloproteinases in tuberculosis – diabetes co-morbidity. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Preprints. https://doi.org/10.1016/j.jctube.2021.100237

Chicago

Pavan Kumar, Nathella, Kadar Moideen, Vijay Viswanathan, Shanmugam Sivakumar, Syed Hissar, Hardy Kornfeld, and Subash Babu. 2021. “Effect of Anti-Tuberculosis Treatment on the Systemic Levels of Tissue Inhibitors of Metalloproteinases in Tuberculosis – Diabetes Co-Morbidity.” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, no. Preprints (January). doi:10.1016/j.jctube.2021.100237.